(MassDevice) – Johnson & Johnson today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. […]
(MD+DI) – Johnson & Johnson is offering a preview of its surgical robotics strategy May 13th during its Medical Device Business Review Day in New York. Executives of the New Brunswick, NJ-based company announced the date during a call discussing its 4Q19 results on Wednesday. […]
(Bloomberg) – Johnson & Johnson agreed to pay about $1 billion to resolve most lawsuits claiming it sold defective metal-on-metal hips that ultimately had to be removed, according to people with knowledge of the matter. […]
(MedTech Strategist) – J&J’s recent blockbuster deal for Auris is really just the latest in a series of moves the diversified market giant has made in positioning itself in the exploding field of robotically-enabled surgery. From Verb, its joint venture with Verily, to Orthotaxy to, now, Auris, J&J is developing and advancing what the company calls “a comprehensive digital surgery experience.” […]
(MassDevice) – It should come as no surprise that J&J’s DePuy Synthes business has kept relatively mum about the robotically assisted knee surgery device it’s been developing. J&J entered the competitive surgical orthopedic robot world when DePuy Synthes bought Paris-based Orthotaxy and its orthopedic-surgery robot prototype in 2018. […]
(Motley Fool) – J&J’s latest acquisition might appear to threaten its partnership with Alphabet to develop robotic surgical systems. But another player could be affected even more. […]
Copyright © 2023 | MH Magazine WordPress Theme by MH Themes